Lygos

About:

Lygos provides biotechnology solutions for today’s renewable chemical challenges.

Top Investors: National Science Foundation, Y Combinator, US Department of Energy, U.S. Department of Agriculture, LG Technology Ventures

Description:

Lygos is providing biotechnology solutions for today’s renewable chemical challenges. They engineer microbes to convert sugars into high-value, industrial chemicals, targeting compounds where biological production is cost-advantaged over petrochemical production. The company's throughput screening and strain construction facilitate the rapid optimization of pathways to convert cheap and renewable feedstock to high-value chemicals. Founded in 2011, Lygos is headquartered in Berkeley, California.

Total Funding Amount:

$212M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Berkeley, California, United States

Founded Date:

2011-01-01

Contact Email:

contact(AT)lygos.com

Founders:

Eric Steen, Jay Keasling, Jeffrey Dietrich

Number of Employees:

51-100

Last Funding Date:

2022-04-18

IPO Status:

Private

Industries: